Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 38.35B | 34.18B | 34.07B | 30.09B | 28.44B |
Gross Profit | 9.75B | 8.30B | 7.71B | 6.89B | 6.23B |
EBITDA | 6.82B | 3.74B | 2.98B | 2.97B | 2.43B |
Net Income | 3.78B | 2.42B | 2.04B | 2.06B | 1.21B |
Balance Sheet | |||||
Total Assets | 82.70B | 82.02B | 70.98B | 67.30B | 65.20B |
Cash, Cash Equivalents and Short-Term Investments | 12.91B | 13.84B | 14.87B | 17.34B | 15.12B |
Total Debt | 5.00B | 5.00B | 21.00M | 34.00M | 9.00M |
Total Liabilities | 22.68B | 21.72B | 14.68B | 12.93B | 11.87B |
Stockholders Equity | 59.65B | 59.98B | 56.16B | 54.24B | 53.20B |
Cash Flow | |||||
Free Cash Flow | -771.00M | -6.13B | -3.49B | 1.35B | 2.58B |
Operating Cash Flow | 4.72B | -461.00M | 1.49B | 3.15B | 3.93B |
Investing Cash Flow | -3.30B | -3.82B | -2.81B | -159.00M | -563.00M |
Financing Cash Flow | -2.40B | 3.83B | -1.00B | -863.00M | -803.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥28.91B | 12.31 | 4.39% | 4.40% | 18.82% | ||
78 Outperform | ¥37.53B | 10.55 | 3.48% | 12.21% | 60.18% | ||
75 Outperform | ¥46.22B | 26.65 | 2.16% | 11.54% | 121.00% | ||
73 Outperform | ¥55.81B | 12.60 | 2.98% | 2.75% | -0.09% | ||
66 Neutral | ¥35.12B | 26.30 | 2.16% | 8.00% | -50.92% | ||
65 Neutral | $10.86B | 15.57 | 5.28% | 1.92% | 3.13% | -27.76% | |
65 Neutral | ¥34.13B | 25.33 | 1.97% | 0.68% | -22.82% |